Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about RELX Plc
RELX Plc News
RELX Plc Quantitative Score
About RELX Plc
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the events business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
RELX Plc Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
RELX Plc Financials
Table Compare
Compare RELX metrics with: | |||
|---|---|---|---|
Earnings & Growth | RELX | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | RELX | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | RELX | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | RELX | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
RELX Plc Income
RELX Plc Balance Sheet
RELX Plc Cash Flow
RELX Plc Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Neutral |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
RELX Plc Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 1.5952 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-09-16 | 0.26341 | Quarterly |
| 2025-06-25 | 0.55861 | Quarterly |
| 2024-09-10 | 0.23924 | Quarterly |
| 2024-06-18 | 0.53396 | Quarterly |
| 2023-09-12 | 0.21176 | Quarterly |
Historical Market Cap
Shares Outstanding
RELX Plc Executives
| Name | Role |
|---|---|
| Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBA | Chief Executive Officer & Executive Director |
| Mr. Nicholas Lawrence Luff | Chief Financial Officer & Executive Director |
| Ms. Rosemary Thomson | Chief Human Resources Officer |
| Mr. Mark Kelsey | Chief Executive Officer of Risk |
| Ms. Kumsal Bayazit Besson | Chief Executive Officer of Scientific, Technical & Medical |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBA | Chief Executive Officer & Executive Director | Male | 1963 | 5.2M |
| Mr. Nicholas Lawrence Luff | Chief Financial Officer & Executive Director | Male | 1967 | 3.01M |
| Ms. Rosemary Thomson | Chief Human Resources Officer | Female | 1969 | -- |
| Mr. Mark Kelsey | Chief Executive Officer of Risk | Male | -- | |
| Ms. Kumsal Bayazit Besson | Chief Executive Officer of Scientific, Technical & Medical | Female | 1974 | -- |